POINT Biopharma Global Inc.
NASDAQ:PNT
12.5 (USD) • At close December 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Operating Activities: | ||||
| Net Income
| 98.293 | -45.902 | -13.373 | -0.037 |
| Depreciation & Amortization
| 1.395 | 0.012 | 0 | 0 |
| Deferred Income Tax
| 1.387 | 0.066 | 0 | 0 |
| Stock Based Compensation
| 3.546 | 2.303 | 1.761 | 0 |
| Change In Working Capital
| 80.852 | -1.176 | 3.304 | 0 |
| Accounts Receivables
| 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 |
| Accounts Payables
| 4.825 | -2.022 | 3.597 | 0 |
| Other Working Capital
| 76.026 | 0.846 | -0.293 | 0 |
| Other Non Cash Items
| -1.954 | 0 | 0.005 | 0.037 |
| Operating Cash Flow
| 183.519 | -44.699 | -8.303 | 0 |
| Investing Activities: | ||||
| Investments In Property Plant And Equipment
| -12.767 | -8.802 | -9.797 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -253.498 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -266.265 | -8.802 | -9.797 | 0 |
| Financing Activities: | ||||
| Debt Repayment
| 0 | 0 | 0 | 0 |
| Common Stock Issued
| 130.306 | 264.883 | 25.426 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.053 | 20.45 | 3.221 | 0 |
| Financing Cash Flow
| 130.359 | 281.77 | 28.647 | 0 |
| Other Information: | ||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 |
| Net Change In Cash
| 47.612 | 228.269 | 10.547 | 0 |
| Cash At End Of Period
| 286.428 | 238.816 | 10.547 | 0 |